| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1052307066 |
| P356 | DOI | 10.1007/S00436-008-0891-X |
| P8608 | Fatcat ID | release_dnhmafrx45a7nlzoqlpml7ck2a |
| P698 | PubMed publication ID | 18256853 |
| P50 | author | Annette Kaiser | Q40204430 |
| Sabine Specht | Q91075224 | ||
| P2093 | author name string | Dorian Bevec | |
| Chris Meier | |||
| Ilona Hauber | |||
| Joachim Hauber | |||
| Achim Hoerauf | |||
| Salem Ramadan Sarite | |||
| Ulf F Görbig | |||
| P2860 | cites work | Human malarial disease: a consequence of inflammatory cytokine release | Q21034098 |
| Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A | Q24321701 | ||
| The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A) | Q24649859 | ||
| In the human malaria parasite Plasmodium falciparum, polyamines are synthesized by a bifunctional ornithine decarboxylase, S-adenosylmethionine decarboxylase | Q27974128 | ||
| The spermidine synthase of the malaria parasite Plasmodium falciparum: molecular and biochemical characterisation of the polyamine synthesis enzyme | Q27974262 | ||
| Modification of eukaryotic initiation factor 5A from Plasmodium vivax by a truncated deoxyhypusine synthase from Plasmodium falciparum: An enzyme with dual enzymatic properties | Q27974776 | ||
| A new crystal structure of deoxyhypusine synthase reveals the configuration of the active enzyme and of an enzyme.NAD.inhibitor ternary complex | Q28257755 | ||
| Extracellular (axenic) development in vitro of the erythrocytic cycle of Plasmodium falciparum | Q30530974 | ||
| Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans | Q30661769 | ||
| Role of eIF5A in TNF-alpha-mediated apoptosis of lamina cribrosa cells | Q33207418 | ||
| Cloning, expression and functional activity of deoxyhypusine synthase from Plasmodium vivax | Q33260506 | ||
| Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy | Q33565483 | ||
| A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma. | Q33941996 | ||
| CNI-1493 inhibits monocyte/macrophage tumor necrosis factor by suppression of translation efficiency. | Q34380078 | ||
| Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone | Q34381322 | ||
| Immunological processes in malaria pathogenesis. | Q34447833 | ||
| Tumor necrosis factor ? in the pathogenesis of cerebral malaria | Q35541025 | ||
| Semapimod. Cytokine. | Q35647135 | ||
| Biological therapies for inflammatory bowel disease: research drives clinics. | Q36536248 | ||
| Targeting enzymes involved in spermidine metabolism of parasitic protozoa--a possible new strategy for anti-parasitic treatment. | Q38349539 | ||
| Stimulated expression of mRNAs in activated T cells depends on a functional CRM1 nuclear export pathway. | Q40297353 | ||
| The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells | Q44517465 | ||
| Screening assay for the identification of deoxyhypusine synthase inhibitors | Q45008583 | ||
| Antisense suppression of deoxyhypusine synthase in tomato delays fruit softening and alters growth and development | Q46542243 | ||
| Specific inhibition of c-Raf activity by semapimod induces clinical remission in severe Crohn's disease | Q46635950 | ||
| Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria | Q48037129 | ||
| eIF5A binds to translational machinery components and affects translation in yeast | Q58322099 | ||
| Plasmodium falciparum growth in deep culture | Q70278744 | ||
| P433 | issue | 6 | |
| P921 | main subject | malaria | Q12156 |
| P304 | page(s) | 1177-1184 | |
| P577 | publication date | 2008-02-07 | |
| P1433 | published in | Parasitology Research | Q15755242 |
| P1476 | title | The guanylhydrazone CNI-1493: an inhibitor with dual activity against malaria-inhibition of host cell pro-inflammatory cytokine release and parasitic deoxyhypusine synthase | |
| P478 | volume | 102 |
| Q38943825 | Design, synthesis, and evaluation of guanylhydrazones as potential inhibitors or reactivators of acetylcholinesterase. |
| Q38770059 | Experimental Anti-Inflammatory Drug Semapimod Inhibits TLR Signaling by Targeting the TLR Chaperone gp96. |
| Q34395707 | Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies |
| Q37367535 | Iminoguanidines as Allosteric Inhibitors of the Iron-Regulated Heme Oxygenase (HemO) of Pseudomonas aeruginosa |
| Q34303004 | In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway |
| Q41956540 | New furin inhibitors based on weakly basic amidinohydrazones |
| Q37817830 | Peroxisome proliferator activating receptor (PPAR) in cerebral malaria (CM): a novel target for an additional therapy |
| Q37541047 | The multi-target effects of CNI-1493: convergence of anti-amylodogenic and anti-inflammatory properties in animal models of Alzheimer's disease |
Search more.